ANIK — Anika Therapeutics Share News
0.000.00%
Last trade - 00:00- $191.87m
- $150.85m
- $112.82m
-Caligan urges Anika Therapeutics to conduct review, plans board challenge (updated)
Brief: Caligan Partners Issues Open Letter To Anika Board
Caligan urges Anika Therapeutics to conduct strategic review, plans board challenge
U.S. RESEARCH ROUNDUP-Amyris, HanesBrands, Roblox
Brief: Anika Therapeutics Inc Reports Quarterly Loss Per Share Of $0.29
Advisory: Stock alerts on Anika Therapeutics and Sasol withdrawn
Anika Therapeutics up as pain relief drug meets main goal in late-stage study
Brief: Anika’S Cingal Successfully Achieves Primary Endpoint In Third Phase Study
Brief: Anika Therapeutics Inc - Limited Market Release And First Surgeries Performed Using X-Twist Fixation System
Brief: Anika Therapeutics Q2 Adjusted Loss Per Share $0.12
Brief: Anika Receives FDA 510(K) Clearance For The X-Twist Knotless Fixation System
U.S. RESEARCH ROUNDUP- Black Knight, Dish Network, Whirlpool
Brief: Anika Therapeutics Q1 Loss Per Share $0.20
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:35 AM
Brief: Anika Reports Q4 Adjusted Loss Per Share $0.23
Brief: Anika Reports Third Quarter 2021 Financial Results
Brief: Anika Appoints Sheryl Conley To Board Of Directors
Anika Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Anika Therapeutics Reports Second Quarter Results